Please login to the form below

Not currently logged in
Email:
Password:

Hollingsworth leaves cancer charity for ABPI

Andrew Hollingsworth appointed policy manager at pharma industry body

Andrew Hollingsworth is to leave the third sector to join industry, moving from Cancer Research UK to the Association of the British Pharmaceutical Industry (ABPI).

Hollingsworth will join the UK pharma trade body on November 25 as policy manager. He leaves his role as public affairs manager at Cancer Research UK.

He will use his experience in the third sector in his new role, which will see him lead the ABPI's work to engage with patient groups. This includes the Patient Organisation Forum, which aims to identify mutual interest and improve collaboration between industry and patient organisations.

Hollingsworth also has industry experience spending more than five years at Novartis a senior manager, public affairs. This followed a period in politics as parliamentary assistant in the European Parliament.

Commenting on his new role, Hollingsworth said: “I am keen to develop the ABPI's engagement with patient organisations in an open, transparent and constructive dialogue."

13th November 2013

From: Research, Sales, Marketing, Regulatory, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...